Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
PSAB
MCID: PLY068
MIFTS: 40

Polysubstance Abuse (PSAB)

Categories: Genetic diseases
Genes Variations Tissues Related diseases Publications Pathways Drugs
Sources

Aliases & Classifications for Polysubstance Abuse

About this section

MalaCards integrated aliases for Polysubstance Abuse:

Name: Polysubstance Abuse 57 55 73
Polysubstance Abuse, Susceptibility to 57 29 6 40
Drug Addiction, Susceptibility to 57 13
Drug Addiction 57 55
Drug Dependence 73
Psab 57

Classifications:

MalaCards categories:
Global: Genetic diseases
See all MalaCards categories (disease lists)


External Ids:

OMIM 57 606581
Sources

Summaries for Polysubstance Abuse

About this section
MalaCards based summary : Polysubstance Abuse, also known as polysubstance abuse, susceptibility to, is related to substance dependence and pathological gambling. An important gene associated with Polysubstance Abuse is FAAH (Fatty Acid Amide Hydrolase), and among its related pathways/superpathways are Circadian entrainment and Monoamine GPCRs. The drugs Cocaine and Analgesics have been mentioned in the context of this disorder. Affiliated tissues include brain, liver and heart, and related phenotypes are behavior/neurological and homeostasis/metabolism

Description from OMIM: 606581
Sources

Related Diseases for Polysubstance Abuse

About this section

Diseases related to Polysubstance Abuse via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 127)
# Related Disease Score Top Affiliating Genes
1 substance dependence 31.7 CNR1 DRD2 DRD3
2 pathological gambling 29.9 DRD2 DRD3
3 traumatic brain injury 29.8 COMT DRD2
4 brain injury 29.8 COMT DRD2
5 anxiety 29.7 CNR1 COMT
6 drug dependence 29.6 CNR1 DRD2 DRD3
7 substance abuse 29.5 COMT DRD2 DRD3
8 alcohol abuse 29.5 CNR1 DRD2 DRD3 FAAH
9 personality disorder 29.4 COMT DRD2
10 attention deficit-hyperactivity disorder 29.4 COMT DRD2 DRD3
11 tobacco addiction 29.2 COMT DRD2
12 eating disorder 29.2 CNR1 COMT DRD2
13 obsessive-compulsive disorder 29.1 COMT DRD2 DRD3
14 autism 29.0 COMT DRD2 DRD3
15 schizophrenia 28.8 CNR1 COMT DRD2 DRD3
16 alcohol dependence 28.8 CNR1 COMT DRD2 DRD3 FAAH
17 endocarditis 10.1
18 hallucinogen dependence 10.1 CNR1 FAAH
19 autoimmune encephalitis 10.1 CNR1 FAAH
20 pain agnosia 10.0 CNR1 FAAH
21 agnosia 10.0 CNR1 FAAH
22 delusional disorder 10.0 DRD2 DRD3
23 melanoma 10.0
24 hepatitis d 10.0
25 impulse control disorder 10.0 DRD2 DRD3
26 drug-induced mental disorder 10.0 CNR1 DRD2
27 acute leukemia 10.0
28 hepatitis 10.0
29 leukemia 10.0
30 subdural empyema 10.0
31 dysthymic disorder 10.0
32 mononeuritis multiplex 10.0
33 hepatitis c 10.0
34 bacterial meningitis 10.0
35 meningitis 10.0
36 depression 10.0
37 drug psychosis 10.0 CNR1 DRD2
38 bruxism 10.0 DRD2 DRD3
39 migraine without aura 10.0 DRD2 DRD3
40 opiate dependence 10.0 DRD2 DRD3
41 cocaine dependence 10.0 DRD2 DRD3
42 malaria 10.0
43 infective endocarditis 10.0
44 persistent generalized lymphadenopathy 10.0
45 somatoform disorder 9.9 COMT FAAH
46 movement disease 9.9 DRD2 DRD3
47 schizophreniform disorder 9.9 COMT DRD2
48 oppositional defiant disorder 9.9 COMT DRD2
49 alexithymia 9.9 COMT DRD2
50 opioid addiction 9.9 COMT DRD2

Graphical network of the top 20 diseases related to Polysubstance Abuse:



Diseases related to Polysubstance Abuse
Sources

Symptoms & Phenotypes for Polysubstance Abuse

About this section

Clinical features from OMIM:

606581

MGI Mouse Phenotypes related to Polysubstance Abuse:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.55 CNR1 COMT DRD2 DRD3 FAAH
2 homeostasis/metabolism MP:0005376 9.35 CNR1 COMT DRD2 DRD3 FAAH
3 nervous system MP:0003631 9.02 CNR1 COMT DRD2 DRD3 FAAH
Sources

Drugs & Therapeutics for Polysubstance Abuse

About this section

Drugs for Polysubstance Abuse (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 6)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cocaine Approved, Illicit Phase 2 50-36-2 5760 446220
2 Analgesics
3 Narcotics
4 Analgesics, Opioid
5 Central Nervous System Depressants
6 Peripheral Nervous System Agents

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Abstinence-Linked Money Management Multisite Completed NCT01327586 Phase 2
2 Opioid/Benzodiazepine Polydrug Abuse Recruiting NCT03696017

Search NIH Clinical Center for Polysubstance Abuse

Sources

Genetic Tests for Polysubstance Abuse

About this section

Genetic tests related to Polysubstance Abuse:

# Genetic test Affiliating Genes
1 Polysubstance Abuse, Susceptibility to 29 FAAH
Sources

Anatomical Context for Polysubstance Abuse

About this section

MalaCards organs/tissues related to Polysubstance Abuse:

41
Brain, Liver, Heart, Lung
Sources

Publications for Polysubstance Abuse

About this section

Articles related to Polysubstance Abuse:

(show all 32)
# Title Authors Year
1
Hydrops and fetal hypoplastic left heart: An unexpected improvement after cessation of maternal polysubstance abuse. ( 30194993 )
2018
2
Prevalence of Polysubstance Abuse and Dual Diagnosis in Patients Admitted to Alcohol Rehabilitation Units for Alcohol-Related Problems in Italy: Changes in 15 Years. ( 29016981 )
2017
3
Corrigendum to "Subdural Empyema Complicating Bacterial Meningitis: A Challenging Diagnosis in a Patient with Polysubstance Abuse". ( 29348757 )
2017
4
Active Polysubstance Abuse Concurrent With Surgery as a Possible Newly Identified Infection Risk Factor in Inflatable Penile Prosthesis Placement Based on a Retrospective Analysis of Health and Socioeconomic Factors. ( 26928774 )
2016
5
Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse. ( 26582145 )
2016
6
Subdural Empyema Complicating Bacterial Meningitis: A Challenging Diagnosis in a Patient with Polysubstance Abuse. ( 26543484 )
2015
7
Polysubstance abuse: alcohol, opioids and benzodiazepines require coordinated engagement by society, patients, and physicians. ( 25671013 )
2015
8
Bedside Nurse-Driven Protocol for Management of Alcohol/Polysubstance Abuse Withdrawal. ( 26628550 )
2015
9
Anabolic androgenic steroids and violent offending: confounding by polysubstance abuse among 10,365 general population men. ( 25170826 )
2015
10
Polysubstance abuse related subacute urinary retention and Hutch diverticulum of urinary bladder. ( 24765281 )
2011
11
A case of catatonia secondary to polysubstance abuse and acetaminophen overdose. ( 20582301 )
2010
12
A case of suspected mononeuritis multiplex in a teenager from polysubstance abuse. ( 19769924 )
2009
13
Acculturation and polysubstance abuse in Arab-American treatment clients. ( 20028679 )
2009
14
Infection following treatment of mandible fractures: the role of immunosuppression and polysubstance abuse. ( 17178492 )
2007
15
Polysubstance abuse in liver transplant patients and its impact on survival outcome. ( 18194121 )
2007
16
A 30-year-old man with a history of polysubstance abuse and hepatitis C presents with exertional dyspnea and patchy ground-glass opacities. ( 17099044 )
2006
17
Increased blasts mimicking acute leukemia in a patient with polysubstance abuse. ( 15679445 )
2005
18
The predictive validity of the university of rhode island change assessment questionnaire in a heroin-addicted polysubstance abuse sample. ( 15238052 )
2004
19
Human cannabinoid receptor 1: 5' exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse. ( 15289816 )
2004
20
Treatment of polysubstance abuse in the active user. ( 14996244 )
2004
21
Delayed neuroexcitatory symptoms following propofol sedation in a patient with polysubstance abuse. ( 14507571 )
2003
22
Polysubstance abuse-vulnerability genes: genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms. ( 11704927 )
2001
23
Identification of polysubstance abuse in the parturient. ( 11517135 )
2001
24
Polysubstance abuse and traumatic brain injury: quantitative magnetic resonance imaging and neuropsychological outcome in older adolescents and young adults. ( 10645702 )
1999
25
Zolpidem dependence in a patient with former polysubstance abuse. ( 9211573 )
1997
26
Polysubstance abuse--a case study. ( 8970654 )
1996
27
Dysthymia, depression, and a treatment dilemma in a patient with polysubstance abuse. ( 9384957 )
1996
28
Alcohol and polysubstance abuse among women. ( 7788621 )
1995
29
Cerebral glucose utilization in polysubstance abuse. ( 8526968 )
1995
30
Dopamine transporter gene polymorphisms are not associated with polysubstance abuse. ( 8399824 )
1993
31
Cocaine and polysubstance abuse by psychiatric inpatients. ( 2249807 )
1990
32
Myocardial injury associated with polysubstance abuse. ( 3278579 )
1988
Sources

Variations for Polysubstance Abuse

About this section

ClinVar genetic disease variations for Polysubstance Abuse:

6
# Gene Variation Type Significance SNP ID Assembly Location
1 FAAH NM_001441.2(FAAH): c.385C> A (p.Pro129Thr) single nucleotide variant risk factor rs324420 GRCh37 Chromosome 1, 46870761: 46870761
2 FAAH NM_001441.2(FAAH): c.385C> A (p.Pro129Thr) single nucleotide variant risk factor rs324420 GRCh38 Chromosome 1, 46405089: 46405089
Sources

Expression for Polysubstance Abuse

About this section
Search GEO for disease gene expression data for Polysubstance Abuse.
Sources

Pathways for Polysubstance Abuse

About this section

Pathways related to Polysubstance Abuse according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Circadian entrainment 37
Show member pathways
 12.41 COMT DRD2 DRD3
2
Monoamine GPCRs 1
Show member pathways
 11.38 DRD2 DRD3
3
GPCRs, Other 1
11.27 CNR1 DRD3
4
Nicotine Pathway (Dopaminergic Neuron), Pharmacodynamics 61
Show member pathways
 11.16 DRD2 DRD3
5
Ibuprofen Pathway, Pharmacodynamics 61
10.4 CNR1 FAAH
6
DARPP-32 Phosphorylation 65
9.97 DRD2 DRD3
Sources

GO Terms for Polysubstance Abuse

About this section

Cellular components related to Polysubstance Abuse according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 axon GO:0030424 9.43 CNR1 COMT DRD2
2 integral component of presynaptic membrane GO:0099056 9.37 CNR1 DRD2
3 glutamatergic synapse GO:0098978 9.33 CNR1 DRD2 DRD3
4 endocytic vesicle GO:0030139 9.32 DRD2 DRD3
5 dopaminergic synapse GO:0098691 8.96 DRD2 DRD3
6 GABA-ergic synapse GO:0098982 8.8 CNR1 DRD2 DRD3

Biological processes related to Polysubstance Abuse according to GeneCards Suite gene sharing:

(show all 34)
# Name GO ID Score Top Affiliating Genes
1 response to drug GO:0042493 9.8 COMT DRD2 DRD3
2 response to ethanol GO:0045471 9.69 CNR1 DRD2 DRD3
3 locomotory behavior GO:0007626 9.66 DRD2 DRD3
4 regulation of lipid metabolic process GO:0019216 9.66 CNR1 DRD3
5 learning GO:0007612 9.65 COMT DRD3
6 learning or memory GO:0007611 9.65 CNR1 DRD3
7 circadian regulation of gene expression GO:0032922 9.65 DRD2 DRD3
8 negative regulation of protein kinase B signaling GO:0051898 9.64 DRD2 DRD3
9 visual learning GO:0008542 9.64 DRD2 DRD3
10 response to nicotine GO:0035094 9.63 CNR1 DRD2
11 positive regulation of cytokinesis GO:0032467 9.63 DRD2 DRD3
12 response to amphetamine GO:0001975 9.62 DRD2 DRD3
13 arachidonic acid secretion GO:0050482 9.61 DRD2 DRD3
14 adenylate cyclase-activating adrenergic receptor signaling pathway GO:0071880 9.61 DRD2 DRD3
15 behavioral response to cocaine GO:0048148 9.6 DRD2 DRD3
16 dopamine receptor signaling pathway GO:0007212 9.59 DRD2 DRD3
17 negative regulation of protein secretion GO:0050709 9.58 DRD2 DRD3
18 synaptic transmission, dopaminergic GO:0001963 9.58 DRD2 DRD3
19 prepulse inhibition GO:0060134 9.57 DRD2 DRD3
20 positive regulation of renal sodium excretion GO:0035815 9.56 DRD2 DRD3
21 regulation of synaptic transmission, GABAergic GO:0032228 9.55 CNR1 DRD2
22 G protein-coupled receptor internalization GO:0002031 9.54 DRD2 DRD3
23 adenylate cyclase-inhibiting dopamine receptor signaling pathway GO:0007195 9.52 DRD2 DRD3
24 adenylate cyclase-modulating G protein-coupled receptor signaling pathway GO:0007188 9.5 CNR1 DRD2 DRD3
25 regulation of dopamine uptake involved in synaptic transmission GO:0051584 9.49 DRD2 DRD3
26 negative regulation of dopamine receptor signaling pathway GO:0060160 9.48 DRD2 DRD3
27 acid secretion GO:0046717 9.46 DRD2 DRD3
28 negative regulation of dopamine secretion GO:0033602 9.43 CNR1 DRD2
29 response to cocaine GO:0042220 9.43 CNR1 DRD2 DRD3
30 regulation of locomotion involved in locomotory behavior GO:0090325 9.4 DRD2 DRD3
31 response to histamine GO:0034776 9.37 DRD2 DRD3
32 response to morphine GO:0043278 9.33 CNR1 DRD2 DRD3
33 negative regulation of blood pressure GO:0045776 9.13 CNR1 DRD2 DRD3
34 dopamine metabolic process GO:0042417 8.8 COMT DRD2 DRD3

Molecular functions related to Polysubstance Abuse according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 G protein-coupled receptor activity GO:0004930 9.54 CNR1 DRD2 DRD3
2 adrenergic receptor activity GO:0004935 9.32 DRD2 DRD3
3 dopamine binding GO:0035240 9.26 DRD2 DRD3
4 dopamine neurotransmitter receptor activity, coupled via Gi/Go GO:0001591 9.16 DRD2 DRD3
5 dopamine neurotransmitter receptor activity GO:0004952 8.96 DRD2 DRD3
6 drug binding GO:0008144 8.8 CNR1 DRD2 DRD3
Sources

Sources for Polysubstance Abuse

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....